Compute Health Acquisition (Compute Health Acquisition) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Compute Health Acquisition Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Compute Health Acquisition is: No Data: Cannot be evaluated.

Competitive Comparison of Compute Health Acquisition's Risk Assessment

For the Shell Companies subindustry, Compute Health Acquisition's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Compute Health Acquisition's Risk Assessment Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Compute Health Acquisition's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Compute Health Acquisition's Risk Assessment falls into.

Compute Health Acquisition (NYSE:CPUH.U) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Compute Health Acquisition Risk Assessment Related Terms

Thank you for viewing the detailed overview of Compute Health Acquisition's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Compute Health Acquisition (Compute Health Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Compute Health Acquisition Corp (NYSE:CPUH.U) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

1105 North Market Street, 4th Floor, Wilmington, DE, USA, 19890

Website

https://www.compute-health.com

Compute Health Acquisition Corp is a blank check company.

Executives

Omar Ishrak	director, 10 percent owner	710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Gwendolyn A Watanabe	director	C/O SARATOGA VENTURES, 210 ALMENDRA AVENUE, LOS GATOS CA 95030
Joshua A Fink	director, 10 percent owner	540 MADISON AVENUE, 18TH FLOOR, NEW YORK NY 10022
Michael Harsh	director	3600 GREEN COURT, SUITE 350, ANN ARBOR MI 48105
Compute Health Sponsor Llc	director, 10 percent owner	1105 NORTH MARKET STREET, SUITE 1300, WILMINGTON DE 19801
Hani Barhoush	director	1105 NORTH MARKET STREET, SUITE 1300, WILMINGTON DE 19801
Jean Nehme	director, 10 percent owner	1105 NORTH MARKET STREET, SUITE 1300, WILMINGTON DE 19801
Compute Health Sponsor Ii Llc	director, 10 percent owner	1105 N. MARKET STREET, SUITE 1300, WILIMINGTON DE 19801
Osama Alswailem	director	1105 NORTH MARKET STREET, SUITE 1300, WILMINGTON DE 19801